| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $26.4M | +22.9% |
| R&D Expense | $804K | +3250.0% |
| SG&A Expense | $8.4M | -4.2% |
| Operating Income | -$1.8M | -419.5% |
| Interest Expense | $155K | +355.9% |
| Pre-tax Income | -$1.7M | -132.7% |
| Income Tax | -$92K | -126.9% |
| Net Income | -$1.6M | -133.1% |
| EPS (Basic) | -$0.01 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $1.2M | -15.1% |
| Inventory | $3.7M | -27.0% |
| Current Assets | $5.8M | -26.8% |
| Total Assets | $7.1M | -23.6% |
| Current Liabilities | $4.8M | -13.6% |
| Long-term Debt | $1.4M | +866.7% |
| Total Liabilities | $5.4M | -12.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.7M | -27.7% |
| Capital Expenditures | $189K | +71.8% |
| Investing Cash Flow | -$189K | -71.8% |
| Financing Cash Flow | $1.3M | +44.3% |
| Free Cash Flow | -$1.9M | -31.0% |
| -150.0% |
| EPS (Diluted) | -$0.01 | -200.0% |
| Stockholders' Equity |
| $1.7M |
| -45.7% |